A detailed history of Copley Financial Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Copley Financial Group, Inc. holds 52 shares of NVO stock, worth $4,543. This represents 0.01% of its overall portfolio holdings.

Number of Shares
52
Holding current value
$4,543
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 09, 2024

BUY
$119.07 - $145.42 $6,191 - $7,561
52 New
52 $6.19 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Copley Financial Group, Inc. Portfolio

Follow Copley Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copley Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Copley Financial Group, Inc. with notifications on news.